Jaume Pons

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ALXO

Current role

CEO, Board Member

2015-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Alx Oncology Holdings Inc (ALXO)	Former President and Chief Scientific Officer	$259,199	—	—	$64,530	—	$650,000	$973,729
2024	Alx Oncology Holdings Inc (ALXO)	Former President and Chief Scientific Officer	$650,000	—	$950,400	$1,128,695	$288,860	—	$3,017,955
2023	Alx Oncology Holdings Inc (ALXO)	Former President and Chief Scientific Officer	$649,740	—	$521,540	$1,216,689	$357,357	—	$2,745,326
2022	Alx Oncology Holdings Inc (ALXO)	President, Chief Scientific Officer and former Chief Executive Officer	$583,500	—	$848,780	$2,029,250	$272,786	—	$3,734,316
2021	Alx Oncology Holdings Inc (ALXO)	Chief Executive Officer and President	$566,500	—	—	$9,263,228	$283,250	—	$10,112,978
2020	Alx Oncology Holdings Inc (ALXO)	Chief Executive Officer and President	$487,708	$500,000	—	$5,953,964	$292,759	—	$7,234,431
2019	Alx Oncology Holdings Inc (ALXO)	Chief Executive Officer and President	$422,300	—	—	$134,002	$147,900	—	$704,202

No earnings-call appearances or filed executive changes recorded yet.